Literature DB >> 14583376

Effectiveness of elective stenting of common carotid artery lesions in preventing stroke.

Francisco L Chio1, Ming W Liu, Masroor A Khan, Sriram S Iyer, Gary S Roubin.   

Abstract

We report our experience with elective stenting of lesions only involving the origin and proximal common carotid arteries. In 37 patients (42 vessels), procedural success was 95% (40 of 42 vessels) with 2 minor strokes (4.70%) and no major strokes. Follow-up for a mean of 24 months showed 1 transient ischemic attack, 2 contralateral minor strokes, 1 cerebral hemorrhage associated with long-term warfarin therapy, and a 5.1% restenosis rate. This technique is an excellent alternative for treating proximal and ostial lesions of the common carotid artery.

Entities:  

Mesh:

Year:  2003        PMID: 14583376     DOI: 10.1016/j.amjcard.2003.07.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  A case of tandem stenoses at the proximal common and internal carotid arteries treated with transbrachial stenting: a case report.

Authors:  Hidemichi Ito; Masashi Uchida; Taigen Sase; Yuichiro Kushiro; Tetsuya Ikeda; Hiroshi Takasuna; Ichiro Takumi; Kotaro Oshio; Yuichiro Tanaka
Journal:  Interv Neuroradiol       Date:  2018-11-04       Impact factor: 1.610

2.  Carotid interventions above and below the bulb.

Authors:  George Magoufis; Elias N Brountzos
Journal:  Semin Intervent Radiol       Date:  2007-06       Impact factor: 1.513

3.  Vasopressor use in the critical care unit for treatment of persistent post-carotid artery stent induced hypotension.

Authors:  Mohan Reddi Nandalur; Howard Cooper; Lowell F Satler; Kiran R Nandalur; John R Laird
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

4.  Acute Ischemic Stroke due to Common Carotid Ostial Disease with Tandem Intracranial Occlusions Treated with Thrombectomy and Staged Retrograde Stenting.

Authors:  Krishna Amuluru; Fawaz Al-Mufti; Charles E Romero
Journal:  Interv Neurol       Date:  2018-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.